Shares

Six to buy

Dr. Martens

The Times

onsumer goods and retailing have come under pressure from inflation and supply-chain issues. But Dr. Martens still sold 14.1 million pairs of boots, shoes and sandals last year for the 12 months to the end of March, up by 1.4 million from the year before. This translated into a 43% increase in pre-tax profit and an 18% increase in sales. There’s scope for more growth, especially in Asia. Longer-term investors might want to be wary